Integrated Microbiota–Bile Acid Analysis as Potential NonInvasive Biomarkers for Ulcerative Colitis Staging Diagnose
The FASEB Journal · 2025
DOI: 10.1096/fj.202501078r ↗Kurz gefasst
Fachartikel in der Zeitschrift The FASEB Journal, 2025. Verfasst von Tianyu He und 8 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, P.R. China. Hauptthemen laut MEDLINE: Colitis, Ulcerative, Bile Acids and Salts, Gastrointestinal Microbiome. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 60 Literaturangaben. Gefördert von: the National Key Research and Development Program of China, the National Natural Science Foundation of China, 111 Plan | Overseas Expertise Introduction Project for Discipline Innovation.
Abstract (Originalsprache)
Clinical staging diagnosis and progression tracking for ulcerative colitis (UC) is as challenging as poor patient compliance with endoscopic biopsy. We perform a study that integrates metabolomic profiling, 16S rRNA, and metagenomic sequencing on serum and fecal samples from 23 active state UC patients, 24 remission state UC patients, and 20 healthy volunteers from China, aiming to explore a non‐invasive integrative biochemical index to quantitatively track and monitor pathological activity of UC. Besides the known associations of microbes such as Fusobacterium nucleatum and Clostridium symbiosum with UC, we found several bile acid‐transforming species, including 7α‐dehydroxygenase and 7α/β‐dehydrogenase expressing microbiota, were significantly correlated with UC pathological activity. We identified 2 bacterial gene markers related to secondary bile acid synthesis besides Clostridium scindens that differentiated active and remission stage UC and healthy control microbiomes. Relevantly, reduced serum deoxycholic acid (DCA)/cholic acid (CA) species ratio and increased fecal ursodeoxycholic acid (UDCA)/chenodeoxycholic acid (CDCA) ratio were associated with the pathological activity of UC. Moreover, receiver operating characteristic analysis based on serum/fecal bile acid ratios was much more accurate in the prediction of active and remission stage outcomes. This species‐specific temporal change and bile acid dysregulation pattern linked to disease severity indicate that integrated microbiome–bile acid profiles may be implied for disease activity prediction and that targeting microbiome‐mediated gut flora and bile acid homeostasis may be implicative of therapy efficacy. These insights will help improve clinical diagnosis and optimize existing medical treatments.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing, P.R. China.
- Jiangsu Provincial Key Laboratory of Targetome and Innovative Drugs, Institute of Innovative Drug Discovery and Development, China Pharmaceutical University, Nanjing, P.R. China.
- Department of Gastroenterology, Affiliated Hospital of Nanjing University of Chinese Medicine (Jiangsu Province Hospital of Chinese Medicine), Nanjing, China.
ORCID-Profile: Haiping Hao, Lijuan Cao
Förderung
- the National Key Research and Development Program of China
- the National Natural Science Foundation of China
- 111 Plan | Overseas Expertise Introduction Project for Discipline Innovation
- the Project of State Key Laboratory of Natural Medicines, China Pharmaceutical University
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- Overseas Expertise Introduction Project for Discipline Innovation
Zitieren
APA
He, T., Wang, Y., Zhao, L., Che, Y., Zhang, L., Zeng, Y., Shen, H., Hao, H., & Cao, L. (2025). Integrated Microbiota–Bile Acid Analysis as Potential NonInvasive Biomarkers for Ulcerative Colitis Staging Diagnose. The FASEB Journal. https://doi.org/10.1096/fj.202501078r
Vancouver
He T, Wang Y, Zhao L, Che Y, Zhang L, Zeng Y, et al. Integrated Microbiota–Bile Acid Analysis as Potential NonInvasive Biomarkers for Ulcerative Colitis Staging Diagnose. The FASEB Journal. 2025. doi:10.1096/fj.202501078r
BibTeX
@article{He2025,
author = {He, Tianyu and Wang, Yun and Zhao, Liang and Che, Yuan and Zhang, Lu and Zeng, Yuming and Shen, Hong and Hao, Haiping and Cao, Lijuan},
title = {Integrated Microbiota–Bile Acid Analysis as Potential NonInvasive Biomarkers for Ulcerative Colitis Staging Diagnose},
journal = {The FASEB Journal},
year = {2025},
doi = {10.1096/fj.202501078r}
}
EUVIMED